What Raises Homocysteine
| Cause | Mechanism |
|---|---|
| Vitamin B12 deficiency | Impairs homocysteine breakdown |
| Folate deficiency | Same pathway affected |
| Vitamin B6 deficiency | Alternative pathway affected |
| Kidney disease | Reduced clearance |
| Genetic (MTHFR mutation) | Reduced enzyme efficiency: common but usually mild effect |
| Smoking, high coffee intake | Modest elevation |
Homocysteine and Cardiovascular Risk
High homocysteine is associated with increased risk of heart attack, stroke, and blood clots, likely through effects on blood vessel lining and clotting. However, clinical trials lowering homocysteine with B vitamins have not consistently reduced cardiovascular events, so it remains a marker rather than a definitively modifiable risk factor.How to Lower Homocysteine
- Correct any B12, folate, or B6 deficiency
- Reduce coffee intake if very high
- Stop smoking
- Folic acid + B12 + B6 supplementation can lower levels by 25-30%, though cardiovascular benefit is unproven
References
The clinical information on this page is drawn from peer-reviewed sources indexed by the US National Library of Medicine. Links go to the source so you can read it yourself.
- Hyperhomocysteinemia. In: StatPearls. Treasure Island (FL): StatPearls Publishing. NCBI Bookshelf NBK554408
References
Sources cited on this page. PubMed links open the original abstract.
- Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 2004;50(1):3–32. PMID 14709638 · doi:10.1373/clinchem.2003.021634
How Homocysteine Is Produced and Why Elevated Levels Are Harmful
Homocysteine is a sulphur-containing amino acid produced during the metabolism of methionine, an essential amino acid obtained from dietary protein. Under normal circumstances, homocysteine is rapidly recycled back to methionine via the methylation cycle – a process requiring vitamin B12 and folate as essential cofactors – or converted to cystathionine via the transsulphuration pathway, which requires vitamin B6. When B12, folate, or B6 are deficient, or when the recycling enzyme (MTHFR) is impaired, homocysteine accumulates in the blood.1
Elevated homocysteine (hyperhomocysteinaemia) is associated with endothelial injury through multiple mechanisms: direct oxidative damage to vascular endothelium, increased expression of adhesion molecules that attract inflammatory cells, promotion of platelet aggregation, and stimulation of smooth muscle cell proliferation. These effects collectively promote atherosclerosis and increase thrombotic risk. A meta-analysis of prospective studies published in BMJ found that a 5 μmol/L increase in homocysteine was associated with a 20% increase in coronary heart disease risk and a 59% increase in stroke risk, though causality remains debated as B-vitamin supplementation trials have not consistently reduced cardiovascular events despite lowering homocysteine.2
Normal Range, Classification, and What Your Result Means
The reference range for total plasma homocysteine is typically 5–15 μmol/L in adults, though some laboratories use 5–12 μmol/L as the optimal range. Values are classified as: normal (below 15 μmol/L), mild hyperhomocysteinaemia (15–30 μmol/L), moderate (30–100 μmol/L), and severe (above 100 μmol/L). Homocysteine rises naturally with age and is approximately 10–15% higher in men than women due to higher muscle mass and methionine turnover. It also rises during pregnancy as folate demands increase, in renal impairment (as the kidney is the major site of homocysteine clearance), in hypothyroidism, and with certain medications – methotrexate, phenytoin, and theophylline all raise homocysteine by interfering with folate metabolism.
When Homocysteine Testing Is Clinically Appropriate
Routine population screening for homocysteine is not currently recommended by major guidelines because lowering it with B vitamins has not been shown to reduce cardiovascular events in low-risk individuals. However, testing is clinically justified in specific contexts: investigation of premature cardiovascular disease (men under 55, women under 65) where conventional risk factors do not fully explain the risk; unexplained recurrent venous thromboembolism, particularly in younger patients; evaluation of suspected B12 or folate deficiency when serum levels are in the low-normal range (methylmalonic acid and homocysteine are the functional markers of B12 status, more sensitive than serum B12 alone); and in the diagnosis and monitoring of homocystinuria – the rare inherited metabolic disorder (CBS enzyme deficiency) where homocysteine levels exceed 100 μmol/L and cause lens dislocation, skeletal abnormalities, intellectual disability, and very early vascular disease.3
Related reading
- Heart Health Blood Tests: Complete GuideWhich blood tests assess heart health? Complete guide to cholesterol…
- Guide to Vitamin Deficiency Blood TestsWhich blood tests detect vitamin deficiencies? Learn how to test for…
- Vitamin & Mineral DeficiencyWhich blood tests check for vitamin deficiencies? Learn about Vitamin…
- Low-Dose Aspirin: Who Should Take It and WhyShould you take low-dose aspirin for heart disease prevention?…
- Child Health Blood Tests: A Parent's GuideWhat blood tests are recommended for children? A guide to common…
- Hypertension: Understanding and Managing High Blood PressuHypertension affects 1 in 4 adults and is the leading cause of stroke…
Why lowering homocysteine has not translated into fewer heart attacks
Homocysteine is reliably associated with cardiovascular disease in observational studies, which made it an attractive treatment target. However, large randomised trials of B vitamins that successfully lowered homocysteine did not produce the expected reduction in heart attacks or cardiovascular death. The most likely explanation is that raised homocysteine is a marker of risk rather than a cause of it, travelling alongside kidney impairment, poor nutrition and other factors that carry the real risk. This is why routine homocysteine testing is not recommended for cardiovascular risk assessment in the general population, and why a raised level is not by itself a reason to start supplements.
Where the test genuinely helps
- Suspected B12 deficiency with a borderline B12 level, where homocysteine and methylmalonic acid both rise and help confirm true tissue deficiency.
- Distinguishing B12 from folate deficiency: homocysteine rises in both, but methylmalonic acid rises only in B12 deficiency.
- Suspected homocystinuria, an inherited metabolic disorder presenting with lens dislocation, skeletal abnormalities, learning difficulty and early thrombosis, where levels are extremely high.
- Unexplained venous thrombosis in a young person, as part of a broader assessment.
Sample handling changes the result
Homocysteine continues to be released from red cells after the blood is drawn, so a sample left at room temperature gives a falsely high result. Samples need to be placed on ice or centrifuged promptly, typically within an hour. An isolated raised homocysteine from a sample that sat in a warm room is a common and avoidable false positive, and is worth asking about before pursuing an unexpected result. Kidney impairment is the other frequent explanation, since homocysteine is cleared renally and rises as eGFR falls.